Telomere transcripts target telomerase in human cancer cells

Genes

Volumn 7, Issue 8, 2016, Pages

  Kreilmeier, Theresa ^a,b   Mejri, Doris ^a   Hauck, Marlene ^c   Kleiter, Miriam ^b   Holzmann, Klaus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Canine; Enzyme inhibition; Human; Long non coding transcript; Telomerase; Telomere; Tumor cell lines; Viral expression systems

Indexed keywords

LONG UNTRANSLATED RNA; RIBONUCLEASE; RNA DIRECTED DNA POLYMERASE; SHORT HAIRPIN RNA; TELOMERASE; TELOMERIC REPEAT CONTAINING RNA; UNCLASSIFIED DRUG;

ADENOVIRIDAE; ARTICLE; CANCER CELL; CELL GROWTH; CELL VIABILITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME ACTIVITY; GENETIC CODE; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; LENTIVIRINAE; OSTEOSARCOMA; POLYADENYLATION; TELOMERE; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA; VIRUS EXPRESSION;

EID: 84983048177     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes7080046     Document Type: Article

References (57)

1. Hanahan, D, Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674. [CrossRef] [PubMed]
2. Armanios, M, Blackburn, E.H. The telomere syndromes. Nat. Rev. Genet. 2012, 13, 693-704. [CrossRef] [PubMed]
3. Bell, R.J, Rube, H.T, Xavier-Magalhães, A, Costa, B.M, Mancini, A, Song, J.S, Costello, J.F. Understanding TERT Promoter Mutations: A Common Path to Immortality. Mol. Cancer Res. 2016, 14, 315-323. [CrossRef] [PubMed]
4. Azzalin, C.M, Reichenbach, P, Khoriauli, L, Giulotto, E, Lingner, J. Telomeric repeat containing RNAand RNA surveillance factors at mammalian chromosome ends. Science 2007, 318, 798-801. [CrossRef] [PubMed]
5. Schoeftner, S, Blasco, M.A. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell Biol. 2008, 10, 228-236. [CrossRef] [PubMed]
6. Nergadze, S.G, Farnung, B.O, Wischnewski, H, Khoriauli, L, Vitelli, V, Chawla, R, Giulotto, E, Azzalin, C.M. CpG-island promoters drive transcription of human telomeres. RNA 2009, 15, 2186-2194. [CrossRef] [PubMed]
7. Redon, S, Reichenbach, P, Lingner, J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res. 2010, 38, 5797-5806. [CrossRef] [PubMed]
8. Sampl, S, Pramhas, S, Stern, C, Preusser, M, Marosi, C, Holzmann, K. Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade. Transl. Oncol. 2012, 5, 56-65. [CrossRef] [PubMed]
9. Ng, L.J, Cropley, J.E, Pickett, H.A, Reddel, R.R, Suter, C.M. Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res. 2009, 37, 1152-1159. [CrossRef] [PubMed]
10. Caslini, C. Transcriptional regulation of telomeric non-coding RNA: Implications on telomere biology, replicative senescence and cancer. RNA Biol. 2010, 7, 18-22. [CrossRef] [PubMed]
11. Feuerhahn, S, Iglesias, N, Panza, A, Porro, A, Lingner, J. TERRA biogenesis, turnover and implications for function. FEBS Lett. 2010, 584, 3812-3818. [CrossRef] [PubMed]
12. Maicher, A, Kastner, L, Luke, B. Telomeres and disease: Enter TERRA. RNA Biol. 2012, 9, 843-849. [CrossRef] [PubMed]
13. Maicher, A, Lockhart, A, Luke, B. Breaking new ground: Digging into TERRA function. Biochim. Biophys. Acta 2014, 1839, 387-394. [CrossRef] [PubMed]
14. Rippe, K, Luke, B. TERRA and the state of the telomere. Nat. Struct. Mol. Biol. 2015, 22, 853-858. [CrossRef] [PubMed]
15. Schoeftner, S, Blasco, M.A. Chromatin regulation and non-coding RNAs at mammalian telomeres. Semin. Cell Dev. Biol. 2010, 21, 186-193. [CrossRef] [PubMed]
16. Nasir, L, Devlin, P, McKevitt, T, Rutteman, G, Argyle, D.J. Telomere lengths and telomerase activity in dog tissues: A potential model system to study human telomere and telomerase biology. Neoplasia 2001, 3, 351-359. [CrossRef] [PubMed]
17. Richter, M, Jurek, D, Wrba, F, Kaserer, K, Wurzer, G, Karner-Hanusch, J, Marian, B. Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur. J. Cancer 2002, 38, 1937-1945. [CrossRef]
18. Willson, J.K, Bittner, G.N, Oberley, T.D, Meisner, L.F.; Weese, J.L. Cell culture of human colon adenomas and carcinomas. Cancer Res. 1987, 47, 2704-2713. [PubMed]
19. Schweiger, N, Hauck, M, Steinhoff, H, Sampl, S, Reifinger, M, Walter, I, Kreilmeier, T, Marian, B, Grusch, M, Berger, W, et al. Canine and human sarcomas exhibit predominant FGFR1 expression and impaired viability after inhibition of signaling. Mol. Carcinog. 2015, 54, 841-852. [CrossRef] [PubMed]
20. Kiyozuka, Y. Correlation of telomerase activity and telomere length to chemosensitivity. Methods Mol. Med. 2005, 111, 97-108. [PubMed]
21. Griffith, J, Bianchi, A, de Lange, T. TRF1 promotes parallel pairing of telomeric tracts in vitro. J. Mol. Biol. 1998, 278, 79-88. [CrossRef] [PubMed]
22. Holzmann, K, Gerner, C, Poltl, A, Schafer, R, Obrist, P, Ensinger, C, Grimm, R, Sauermann, G. A human common nuclear matrix protein homologous to eukaryotic translation initiation factor 4A. Biochem. Biophys. Res. Commun. 2000, 267, 339-344. [CrossRef] [PubMed]
23. Ferraiuolo, M.A, Lee, C.S, Ler, L.W, Hsu, J.L, Costa-Mattioli, M, Luo, M.J, Reed, R, Sonenberg, N. A nuclear translation-like factor eIF4AIII is recruited to the mRNA during splicing and functions in nonsense-mediated decay. Proc. Natl. Acad. Sci. USA 2004, 101, 4118-4123. [CrossRef] [PubMed]
24. Masutomi, K, Yu, E.Y, Khurts, S, Ben-Porath, I, Currier, J.L, Metz, G.B, Brooks, M.W, Kaneko, S, Murakami, S, DeCaprio, J.A, et al. Telomerase maintains telomere structure in normal human cells. Cell 2003, 114, 241-253. [CrossRef]
25. Guiducci, C, Anglana, M, Wang, A, Bacchetti, S. Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells. Exp. Cell Res. 2001, 265, 304-311. [CrossRef] [PubMed]
26. Losert, A, Mauritz, I, Erlach, N, Herbacek, I, Schulte-Hermann, R, Holzmann, K, Grusch, M. Monitoring viral decontamination procedures with green fluorescent protein-expressing adenovirus. Anal. Biochem. 2006, 355, 310-312. [CrossRef] [PubMed]
27. Aschacher, T.; Wolf, B, Enzmann, F, Kienzl, P, Messner, B, Sampl, S, Svoboda, M, Mechtcheriakova, D, Holzmann, K, Bergmann, M. LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines. Oncogene 2016, 35, 94-104. [CrossRef] [PubMed]
28. Aschacher, T, Sampl, S, Kaser, L, Bernhard, D, Spittler, A, Holzmann, K, Bergmann, M. The combined use of known antiviral reverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations. Neoplasia 2012, 14, 44-53. [CrossRef] [PubMed]
29. Wege, H, Chui, M.S, Le, H.T, Tran, J.M, Zern, M.A. SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucleic Acids Res. 2003, 31, E3-E3. [CrossRef] [PubMed]
30. Shay, J.W, Wright, W.E. Hayflick, his limit, and cellular ageing. Nat. Rev. Mol. Cell Biol. 2000, 1, 72-76. [CrossRef] [PubMed]
31. Heinzle, C, Gsur, A, Hunjadi, M, Erdem, Z, Gauglhofer, C, Stattner, S, Karner, J, Klimpfinger, M.; Wrba, F, Reti, A, et al. Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasis. Cancer Res. 2012, 72, 5767-5777. [CrossRef] [PubMed]
32. Bandyopadhyay, D, Gatza, C, Donehower, L.A, Medrano, E.E. Analysis of Cellular Senescence in Culture in Vivo: The Senescence-Associated β-Galactosidase Assay. Curr. Protoc. Cell Biol. 2005. [CrossRef]
33. Shay, J.W. Role of telomeres and telomerase in aging and cancer. Cancer Discov. 2016, 6, 584-593. [CrossRef] [PubMed]
34. Low, K.C, Tergaonkar, V. Telomerase: Central regulator of all of the hallmarks of cancer. Trends Biochem. Sci. 2013, 38, 426-434. [CrossRef] [PubMed]
35. Chiappori, A.A, Kolevska, T, Spigel, D.R, Hager, S, Rarick, M, Gadgeel, S, Blais, N, Von Pawel, J, Hart, L, Reck, M, et al. A randomized phase IIstudy of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer. Ann. Oncol. 2015, 26, 354-362. [CrossRef] [PubMed]
36. Baerlocher, G.M, Oppliger Leibundgut, E, Ottmann, O.G, Spitzer, G, Odenike, O, McDevitt, M.A, Roth, A, Daskalakis, M, Burington, B, Stuart, M, et al. Telomerase inhibitor imetelstat in patients with essential thrombocythemia. New Engl. J. Med. 2015, 373, 920-928. [CrossRef] [PubMed]
37. Tefferi, A, Lasho, T.L, Begna, K.H, Patnaik, M.M, Zblewski, D.L, Finke, C.M, Laborde, R.R.; Wassie, E, Schimek, L, Hanson, C.A, et al. A pilot study of the telomerase inhibitor imetelstat for myelofibrosis. New Engl. J. Med. 2015, 373, 908-919. [CrossRef] [PubMed]
38. Mender, I, Gryaznov, S, Dikmen, Z.G, Wright, W.E, Shay, J.W. Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-20-deoxyguanosine. Cancer Discov. 2015, 5, 82-95. [CrossRef] [PubMed]
39. Porro, A, Feuerhahn, S, Reichenbach, P, Lingner, J. Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways. Mol. Cell. Biol. 2010, 30, 4808-4817. [CrossRef] [PubMed]
40. Arora, R, Lee, Y, Wischnewski, H, Brun, C.M, Schwarz, T, Azzalin, C.M. RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells. Nat. Commun. 2014, 5, 5220. [CrossRef] [PubMed]
41. Episkopou, H, Draskovic, I, Van Beneden, A, Tilman, G, Mattiussi, M, Gobin, M, Arnoult, N, Londono-Vallejo, A, Decottignies, A. Alternative lengthening of telomeres is characterized by reduced compaction of telomeric chromatin. Nucleic Acids Res. 2014, 42, 4391-4405. [CrossRef] [PubMed]
42. Lovejoy, C.A, Li, W, Reisenweber, S, Thongthip, S, Bruno, J, de Lange, T, De, S, Petrini, J.H, Sung, P.A, Jasin, M, et al. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet. 2012, 8, e1002772. [CrossRef] [PubMed]
43. Yu, T.Y, Kao, Y.W, Lin, J.J. Telomeric transcripts stimulate telomere recombination to suppress senescence in cells lacking telomerase. Proc. Natl. Acad. Sci. USA 2014, 111, 3377-3382. [CrossRef] [PubMed]
44. Nasir, L, Gault, E, Campbell, S, Veeramalai, M, Gilbert, D, McFarlane, R, Munro, A, Argyle, D.J. Isolation and expression of the reverse transcriptase component of the Canis familiaris telomerase ribonucleoprotein (dogTERT). Gene 2004, 336, 105-113. [CrossRef] [PubMed]
45. Argyle, D.J, Nasir, L. Telomerase: A potential diagnostic and therapeutic tool in canine oncology. Vet. Pathol. 2003, 40, 1-7. [CrossRef] [PubMed]
46. Pang, L.Y, Argyle, D. Cancer stem cells and telomerase as potential biomarkers in veterinary oncology. Vet. J. 2010, 185, 15-22. [CrossRef] [PubMed]
47. Cusanelli, E, Romero, C.A, Chartrand, P. Telomeric noncoding RNA TERRA is induced by telomere shortening to nucleate telomerase molecules at short telomeres. Mol. Cell 2013, 51, 780-791. [CrossRef] [PubMed]
48. Smekalova, E, Baumann, P. TERRA-A calling card for telomerase. Mol. Cell 2013, 51, 703-704. [CrossRef] [PubMed]
49. Kong, W, Lv, N, Wysham, W.Z, Roque, D.R, Zhang, T, Jiao, S, Song, D, Chen, J, Bae-Jump, V.L, Zhou, C. Knockdown of hTERT and treatment with BIBR1532 inhibit cell proliferation and invasion in endometrial cancer cells. J. Cancer 2015, 6, 1337-1345. [CrossRef] [PubMed]
50. Xu, T, Rao, Y, Zhu, W, Guo, F. Inhibition of cell growth and telomerase activity in osteosarcoma cells by DN-hTERT. J. Huazhong Univ. Sci. Technol. Med. Sci. 2006, 26, 601-603. [CrossRef] [PubMed]
51. Zhang, X, Mar, V, Zhou, W, Harrington, L, Robinson, M.O. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 1999, 13, 2388-2399. [CrossRef] [PubMed]
52. Bojovic, B, Crowe, D.L. Resistance to telomerase inhibition by human squamous cell carcinoma cell lines. Int. J. Oncol. 2011, 38, 1175-1181. [PubMed]
53. Samy, M, Gattolliat, C.H, Pendino, F, Hillion, J, Nguyen, E, Bombard, S, Douc-Rasy, S, Benard, J, Segal-Bendirdjian, E. Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant. Mol. Cancer Ther. 2012, 11, 2384-2393. [CrossRef] [PubMed]
54. Blackburn, E.H. Telomeres: Structure and synthesis. J. Biol. Chem. 1990, 265, 5919-5921. [PubMed]
55. Lipps, H.J, Rhodes, D. G-quadruplex structures: In vivo evidence and function. Trends Cell Biol. 2009, 19, 414-422. [CrossRef] [PubMed]
56. Hirashima, K, Seimiya, H. Telomeric repeat-containing RNA/G-quadruplex-forming sequences cause genome-wide alteration of gene expression in human cancer cells in vivo. Nucleic Acids Res. 2015, 43, 2022-2032. [CrossRef] [PubMed]
57. Robin, J.D, Ludlow, A.T, Batten, K, Magdinier, F, Stadler, G, Wagner, K.R, Shay, J.W, Wright, W.E. Telomere position effect: Regulation of gene expression with progressive telomere shortening over long distances. Genes Dev. 2014, 28, 2464-2476. [CrossRef] [PubMed]